Therapeutics and inflammatory bowel disease: A guide to the interpretation of randomized controlled trials

被引：25
|
作者：
Feagan, BG
McDonald, JWD
Koval, JJ
机构：
[1] UNIV WESTERN ONTARIO, DEPT MED, LONDON, ON, CANADA
[2] UNIV WESTERN ONTARIO, DEPT EPIDEMIOL & BIOSTAT, LONDON, ON, CANADA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 01期
关键词：
D O I：
10.1053/gast.1996.v110.pm8536868
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Randomized controlled trials are the optimal means of assessing the efficacy of new treatments, This report reviews the methodology of clinical trials in inflammatory bowel disease using examples from recent randomized trials of therapy for Crohn's disease and other gastrointestinal diseases to show key principles, Guidelines for the practicing clinician to evaluate these studies are provided.
引用
收藏
页码：275 / 283
页数：9
相关论文
共 50 条
  • [31] Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients
    Uzzan, Mathieu
    Georgiev, Georgi
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Narula, Neeraj
    Jairath, Vipul
    Ungaro, Ryan
    Burisch, Johan
    Kirchgesner, Julien
    Verstock, Bram
    Hussain, Fez
    Reinisch, Walter
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [32] Are Patients Enrolled in Randomized Controlled Trials (RCTs) Representative of the General Inflammatory Bowel Disease (IBD) Patient Population?
    Ha, Christina Y.
    Ullman, Thomas A.
    Siegel, Corey A.
    Kornbluth, Asher
    GASTROENTEROLOGY, 2011, 140 (05) : S113 - S113
  • [33] Helminths in alternative therapeutics of inflammatory bowel disease
    Pandey, Himani
    Tang, Daryl W. T.
    Wong, Sunny H.
    Lal, Devi
    INTESTINAL RESEARCH, 2024,
  • [34] New cytokine therapeutics for inflammatory bowel disease
    Stokkers, PCF
    Hommes, DW
    CYTOKINE, 2004, 28 (4-5) : 167 - 173
  • [35] Novel targets for inflammatory bowel disease therapeutics
    Löwenberg M.
    D'Haens G.
    Current Gastroenterology Reports, 2013, 15 (2)
  • [36] THERAPEUTICS IN INFLAMMATORY BOWEL-DISEASE - INTRODUCTION
    MULDER, CJJ
    NETHERLANDS JOURNAL OF MEDICINE, 1989, 35 : S1 - S2
  • [37] Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study
    Puolanne, Anna-Maija
    Kolho, Kaija-Leena
    Alfthan, Henrik
    Farkkila, Martti
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (07) : 849 - 854
  • [38] ASSESSING OUTCOME IN RANDOMIZED CLINICAL-TRIALS - INFLAMMATORY BOWEL-DISEASE
    IRVINE, EJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (07): : 561 - 567
  • [39] The fragility of randomized clinical trials in evaluating novel therapies for Inflammatory Bowel Disease
    Chen, R.
    Zheng, J.
    Huang, P.
    Li, L.
    Chen, M.
    Zhang, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1414 - i1414
  • [40] The Quality of Reporting Inflammatory Bowel Disease Randomized Control Trials: A Systematic Review
    Gordon, M.
    Khudr, J.
    Sinopolou, V.
    Lakunina, S.
    Rane, A.
    Akobeng, A.
    BRITISH JOURNAL OF SURGERY, 2023, 110
12345